Clinical Trial Update: Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induction and consolidation with fludarabine, cytarabine, idarubicin, and venetoclax for acute myeloid leukemia; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• Idarubicin (idarubicin)
• Venclexta (venetoclax)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: RECRUITING